Related Experiment Video
Updated: Apr 21, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Vascular risk factors and Alzheimer's disease
John T O'Brien1, Hugh S Markus
1Department of Psychiatry, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. john.obrien@medschl.cam.ac.uk.
Insights
Vascular factors significantly increase the risk of cognitive decline, including Alzheimer's disease (AD) and vascular dementia. Managing cardiovascular health may help slow AD progression, but more research is needed.
Area of Science:
- Neuroscience and Neurology
- Cardiovascular Science
- Gerontology
Background:
- Vascular factors are recognized risks for cognitive decline, dementia, Alzheimer's disease (AD), and vascular dementia.
- These factors may accelerate Alzheimer's pathology (plaque and tangle formation) or impair its clearance.
Discussion:
- Reviews in BMC Medicine explore the clinical, pathological, and therapeutic links between AD and cardiovascular diseases.
- The precise relationship between vascular factors and AD requires further elucidation.
- High-quality treatment studies are lacking to assess the impact of vascular risk modification on AD progression.
Key Insights:
- Strong clinical and pathological evidence links vascular factors to AD.
- Vascular risk factors appear to influence the development and progression of AD pathology.
- Intervention studies are crucial to validate the role of vascular risk management in AD.
Outlook:
- Further longitudinal studies are needed to understand the mechanisms linking vascular health and AD.
- Therapeutic research should focus on whether treating vascular risk can prevent or delay AD onset.
- Investigating the impact of vascular risk reduction on the clinical progression of AD is essential.
Abstract:
Vascular factors are now established risk factors for cognitive decline, both for dementia and its two main subtypes: Alzheimer's disease (AD) and vascular dementia. Their impact likely goes beyond causing an increase in concurrent vascular pathology, since they have been associated with increasing the risk of degenerative Alzheimer (plaque and tangle) pathology, either by increasing its rate of formation or reducing elimination from the brain, or a mixture of the two. A comprehensive series of reviews published in BMC Medicine, investigates the relationship between AD and cardiovascular diseases and risk factors from a clinical, pathological and therapeutic perspective. Whilst links between vascular factors and AD have clearly been demonstrated at both the clinical and pathological level, the nature of the relationship remains to be fully established and there is a lack of high quality treatment studies examining the extent to which vascular risk modification alters AD disease course. Further longitudinal mechanistic and therapeutic studies are required, especially to determine whether treatment of vascular risk can prevent or delay the onset of AD and/or reduce its rate of clinical progression.
More Related Videos
12:50Lesion Explorer: A Video-guided, Standardized Protocol for Accurate and Reliable MRI-derived Volumetrics in Alzheimer's Disease and Normal Elderly
Published on: April 14, 2014
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
Related Concept Videos
Alzheimer Disease l: Introduction
Dementia l: Introduction
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease: Treatment
Dementia
The progression of dementia is generally gradual....